Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and the...
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RADx-UP Coordination and Data Collection: An Infrastructure for COVID-19 Testing Disparities Research.

American journal of public health·2022
Same author

Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.

Bone marrow transplantation·2022
Same author

Basics of Physics and Radiobiology for Radiopharmaceutical Therapies.

Practical radiation oncology·2022
Same author

ASTRO's Framework for Radiopharmaceutical Therapy Curriculum Development for Trainees.

International journal of radiation oncology, biology, physics·2022
Same author

Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.

American journal of hematology·2021
Same author

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.

Cancer discovery·2021

Related Experiment Video

Updated: Jul 3, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Risks to normal tissues from radionuclide therapy.

Ruby Meredith1, Barry Wessels, Susan Knox

  • 1Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL 35249, USA. rmeredith@uabmc.edu

Seminars in Nuclear Medicine
|July 30, 2008
PubMed
Summary

Radionuclide therapy shows variable normal tissue toxicity due to uneven distribution and dosimetry challenges. Improved dose-response data and radiobiologic factors are enhancing treatment predictability.

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Related Experiment Videos

Last Updated: Jul 3, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Area of Science:

  • Oncology
  • Radiology
  • Medical Physics

Background:

  • Radionuclide therapies have advanced, yielding data on radiobiologic effects, including normal tissue toxicity and antitumor efficacy.
  • Normal tissue toxicity data for radionuclides is less extensive and more variable than for external beam radiation.
  • Variability is linked to heterogeneous radionuclide distribution and differing dosimetry methodologies.

Purpose of the Study:

  • To review and update dose-response relationships for radionuclide therapy.
  • To discuss dosimetry and radiobiologic factors influencing treatment outcomes.
  • To consolidate current knowledge on radionuclide therapy's effects.

Main Methods:

  • Review of existing literature on radionuclide therapy in adult malignancies.
  • Analysis of dose-response relationships, focusing on beta-emitting radionuclides.
  • Consideration of dosimetry techniques and radiobiologic principles.

Main Results:

  • Dose-response correlations have improved with better dosimetry and biologic adjustments.
  • Heterogeneous dose distribution complicates whole-organ toxicity assessment.
  • Data primarily from studies involving beta-emitting radionuclides in adult cancer patients.

Conclusions:

  • Accurate dosimetry and understanding radiobiologic factors are crucial for radionuclide therapy.
  • Continued research is needed to refine toxicity prediction and treatment efficacy.
  • Standardization of dosimetry is key to improving therapeutic outcomes.